Clinical Trial Update: Paclitaxel Cationic Liposome (Hepatic Arterial Infusion) in Combination With Systemic Therapy as First-Line Treatment in Colorectal Liver Metastases [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating paclitaxel cationic liposome delivered via hepatic arterial infusion in combination with systemic therapy as first-line treatm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Liver Metastases

Drugs mentioned

• Paclitaxel cationic liposome (hepatic arterial infusion) (paclitaxel in cationic liposome formulation for hepatic arterial infusion)

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Colorectal Liver Metastases, First-line Treatment | Phase 1 | Status: RECRUITING